Safety and Efficacy of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration
Clinical trial NCT02462486 · COMPLETED
Trial details
- NCT number
- NCT02462486
- Sponsor
- Allergan
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-25
- Primary completion
- 2018-04-12
- Enrollment
- 949
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.